Hematologic Malignancy study: Palliative Care
Official title Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
ClinicalTrials.gov ID: NCT05646576
What this study is testing
- What it's testing
- The study wants to see whether a palliative‑care program (called PEACE) can improve quality of life and overall experience for people with lymphoma, leukemia or multiple myeloma who are receiving adoptive cellular therapy.
- Who it's for
- Adults with lymphoma, leukemia or multiple myeloma who are about to receive adoptive cellular therapy.
- What's involved
- Participants will be randomly placed into either a group that gets the PEACE palliative‑care program plus their usual cancer care, or a group that receives usual cancer care only. The program includes scheduled palliative‑care visits and support.
- Time commitment
- The study may last up to 2 years, with regular visits and assessments throughout that period.
- Time commitment: about 2 years
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older.
- Ability to complete surveys in English or with assistance of an interpreter.
- Diagnosis of a hematologic malignancy.
- Receiving autologous adoptive cellular therapy (ACT) at MGH with an FDA approved cellular therapy product.
You likely can't join if
- Impaired cognition or uncontrolled mental illness that prohibits study compliance based on the oncology clinician assessment.
- Already receiving palliative care (PC).
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 2 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.